Cosmos Health CEO swaps $220K debt for shares

Cosmos Health Inc.'s Chief Executive Officer, director and 10% owner Grigorios Siokas reported acquiring 493,495 shares of common stock on January 14, 2026.

Rhea-AI Filing Summary

Cosmos Health Inc.'s Chief Executive Officer, director and 10% owner Grigorios Siokas reported acquiring 493,495 shares of common stock on January 14, 2026. The shares were obtained at $0.4458 per share, described as the fair market value on that date, through a debt exchange agreement with the company.

Under this agreement, Mr. Siokas exchanged $220,000 of debt that the company owed him for these "Exchange Shares". Following the transaction, he beneficially owned 7,738,474 shares of Cosmos Health common stock in direct ownership.

Insider Trade Summary

Net Buyer: 493,495 shares

Net Buy 1 txn

Insider Siokas Grigorios

Role Chief Executive Officer

Bought 493,495 shs ($220K)

Type	Security	Shares	Price	Value
Purchase	Common Stock, par value $.001	493,495	$0.4458	$220K

Holdings After Transaction: Common Stock, par value $.001 — 7,738,474 shares (Direct)

Footnotes (1)

1. F1. Pursuant to a debt exchange agreement by and between Grigorios Siokas, the Company's CEO and the Company (the "Debt Exchange Agreement"), dated as of January 14, 2026, these shares are Exchange Shares (as defined in the Debt Exchange Agreement) being acquired by Mr. Siokas at the Exchange Rate (as defined in the Debt Exchange Agreement) of $0.4458 per share, the fair market value of the Common Stock on January 14, 2026, in exchange for a total amount of $220,000 in debt the Company owed to Mr. Siokas.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Cosmos Health (COSM) report in this Form 4?

Cosmos Health reported that CEO, director and 10% owner Grigorios Siokas acquired 493,495 shares of common stock on January 14, 2026.

At what price did Grigorios Siokas acquire Cosmos Health (COSM) shares?

The 493,495 Cosmos Health common shares were acquired at $0.4458 per share, described as the fair market value of the stock on January 14, 2026.

Was cash paid for the Cosmos Health (COSM) shares in this Form 4 transaction?

No cash was paid; the 493,495 shares were issued to Grigorios Siokas in exchange for $220,000 of debt the company owed him under a Debt Exchange Agreement.

How many Cosmos Health (COSM) shares does Grigorios Siokas own after the transaction?

After the reported transaction, Grigorios Siokas beneficially owned 7,738,474 shares of Cosmos Health common stock in direct ownership.

What type of security is involved in this Cosmos Health (COSM) Form 4 filing?

The filing involves Common Stock, par value $0.001 per share of Cosmos Health Inc.

What agreement governed the share issuance to Grigorios Siokas at Cosmos Health (COSM)?

The issuance was governed by a Debt Exchange Agreement between Cosmos Health Inc. and CEO Grigorios Siokas, dated January 14, 2026, under which he received Exchange Shares for $220,000 of company debt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/15/2026 - 09:40 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Siokas Grigorios

(Last) (First) (Middle)

5 AG. GEORGIOU STR

PILEA

(Street)

THESSALONIKI J3 TK57001

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Cosmos Health Inc. [ COSM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/14/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $.001	01/14/2026	01/14/2026	P(1)		493,495	A	$0.4458	7,738,474	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Pursuant to a debt exchange agreement by and between Grigorios Siokas, the Company's CEO and the Company (the "Debt Exchange Agreement"), dated as of January 14, 2026, these shares are Exchange Shares (as defined in the Debt Exchange Agreement) being acquired by Mr. Siokas at the Exchange Rate (as defined in the Debt Exchange Agreement) of $0.4458 per share, the fair market value of the Common Stock on January 14, 2026, in exchange for a total amount of $220,000 in debt the Company owed to Mr. Siokas.

Remarks:

	/s/ Grigorios Siokas	01/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.